PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke Data From 9 Studies of Blacks and Whites

Author(s):
Kent, S.T.; Rosenson, R.S.; Avery, C.L.; Chen, Y.D.I.; Correa, A.; Cummings, S.R.; Cupples, L.A.; Cushman, M.; Evans, D.S.; Gudnason, V.; Harris, T.B.; Howard, G.; Irvin, M.R.; Judd, S.E.; Jukema, J.W. (0000-0002-3246-8359); Lange, L.; Levitan, E.B.; Li, X.H.; Liu, Y.M.; Post, W.S.; Postmus, I.; Psaty, B.M.; Rotter, J.I.; Safford, M.M.; Sitlani, C.M.; Smith, A.V.; Stewart, J.D.; Trompet, S.; Sun, F.G.; Vasan, R.S.; Woolley, J.M.; Whitsel, E.A.; Wiggins, K.L.; Wilson, J.G.; Muntner, P.
Published
2017
Publication type
Article / Letter to editor
goalsincidencelipoproteins, LDLmeta-analysismyocardial infarctionpolymorphism, single nucleotidestroke
Date issued
2017-08-31
Language
English
Is part of
Circulation: Cardiovascular Genetics (2017), No. 4
hdl
1887/95101
doi
10.1161/CIRCGENETICS.116.001632